Back to search

Switzerland· 47366038

Lutrelef 3,2 mg, Injektionspräparat

A gonadorelin product containing gonadorelinum, registered in Switzerland by Ferring AG and dispensed under Swissmedic category B. The same ATC class is registered in 5 of our 19 countries.

Cat B (Swissmedic)ATC H01CA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLutrelef 3,2 mg, InjektionspräparatATCH01CA01REGISTER NO.47366038PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Gonadorelin is registered in 5 of 19 countries.

Countries holding a registration under ATC H01CA01 (gonadorelin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 2 of them publish a price we can compare per daily dose

Gonadorelin · ATC H01CA01

5 / 19 countries

  • Canada
  • Finlandprice
  • Japan
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
gonadorelinum
Manufacturer
Ferring AG
Country
Switzerland (CH)
ATC code
H01CA01
ATC class
Gonadorelin
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for gonadorelin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gonadorelin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gonadorelin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gonadorelin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Kryptocur
  • United Kingdom (Northern Ireland) · Gonadorelin Intrapharm Laboratories

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8b05a7d-1926-4dbc-843a-82cba325bf01
GET /v1/drugs/b8b05a7d-1926-4dbc-843a-82cba325bf01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about gonadorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.